Please use this identifier to cite or link to this item:
|Title:||Fucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivo|
|Author(s):||Oliveira, Ana Catarina Freitas Salazar|
Granja, Sara Costa
Neves, N. M.
Reis, R. L.
Silva, Tiago José Quinteiros Lopes Henriques
|Citation:||Oliveira C., Granja S., Neves N. M., Reis R. L., Baltazar F., Silva T. H., Martins A. Fucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivo, Carbohydrate Polymers, Vol. 223, doi:10.1016/j.carbpol.2019.115034, 2019|
|Abstract(s):||Fucoidan is a marine-origin sulfated polysaccharide that can show anticancer activity, to which both pro- and anti-angiogenic responses have been reported. Due to this unpredictability, the angiogenic potential of an effective anticancer crude fucoidan (CF), at a concentration of 0.5 mg mL−1 , was evaluated. Tube formation assays demonstrated that CF, either administered while endothelial cells seeding or after their adhesion, migration and organization, inhibited or disrupted the formation of tubular-like structures, respectively. Although CF did not significantly reduced vascular endothelial growth factor (VEGF) secretion, it significantly reduced the expression of platelet-derived growth factor (PDGF), compromising the blood vessels maturation. Two chicken embryo chorioallantoic membrane (CAM) assays were performed: one without tumor (CAM I) and the other with an onplanted tumor mass (CAM II); the CF injection reduced the number of blood of vessels and significantly decreased the tumor size, respectively. In vitro and in vivo results support the effectiveness of fucoidan as a natural antitumor therapeutic agent.|
|Appears in Collections:||3B’s - Artigos em revistas/Papers in scientific journals|
Files in This Item:
|19910-1-s2.0-S0144861719307015-main.pdf||2,59 MB||Adobe PDF||View/Open|